P882: POMALIDOMIDE, DARATUMUMAB, AND DEXAMETHASONE AFTER LENALIDOMIDE TREATMENT IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM): FINAL OVERALL SURVIVAL ANALYSIS OF THE PHASE 2 MM-014 STUDY

ABSTRACT:

SUBMITTER: Bahlis N 

PROVIDER: S-EPMC10431058 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature